Neurotrophic Activity of the Carrageenophyte Kappaphycus alvarezii Cultivated at Different Depths and for Different Growth Periods in Various Areas of Indonesia

Effect of Biomass Drying Protocols on Bioactive Compounds and Antioxidant and Enzymatic Activities of Red Macroalga Kappaphycus alvarezii

Kappaphycus alvarezii is a red seaweed used globally in various biotechnological processes. To ensure the content and stability of its bioactive compounds postharvest, suitable drying protocols must be adopted to provide high-quality raw materials for industrial use. This study aimed to analyze the influence of freeze-drying and oven-drying on the total phenolic content (TPC), total flavonoid content (TFC), antioxidant activity (FRAP and DPPH assays), total carotenoid content (TC), and lipase (LA) and protease activity (PA) of K. alvarezii samples collected over the seasons in sea farms in southern Brazil. The freeze-drying technique was found to be more effective regarding superior contents of TPC (39.23 to 127.74 mg GAE/100 g) and TC (10.27 to 75.33 μg/g), as well as DPPH (6.12 to 8.91 mg/100 g). In turn, oven-drying proved to be the best method regarding the TFC (4.99 to 12.29 mg QE/100 g) and PA (119.50 to 1485.09 U/g), with better performance in the FRAP (0.28 to 0.70 mmol/100 g). In this way, it appears that the drying process of the algal biomass can be selected depending on the required traits of the biomass for the intended industrial application. In terms of cost-effectiveness, drying the biomass using oven-drying can be considered appropriate.

Estudio de la variabilidad en el tiempo y espacio de la actividad antioxidante y composición bioquímica de Kappaphycus alvarezii en diferentes densidades de siembra

Kappaphycus alvarezii es una de las especies de algas más cultivadas en el mundo, debido a su alto contenido de compuestos bioactivos con reportes antioxidantes y bioestimulantes. El presente estudio evaluó el efecto de las densidades de plantación sobre la composición bioquímica y antioxidante de K. alvarezii cultivada en un sistema de línea larga durante las estaciones seca y húmeda, con el fin de proporcionar una base científica para una cosecha óptima. Se midieron el contenido de humedad, cenizas, grasa, fibra, auxinas, fenoles, flavonoides, DPPH y ABTS. Los datos se analizaron mediante pruebas t, Wilcoxon, Kruskal-Wallis y ANOVA unidireccional. Los resultados mostraron un mayor contenido de grasa (2,01 % P.s), fibra bruta (5,21% P.s), contenido total de fenoles (324,09 μg GAE/g P.s) y ABTS (9,32 μg GAE/g P.s) durante la estación seca. Con respecto a la densidad de plantación, se produjo un aumento significativo del contenido en cenizas, fenoles totales y ABTS con una densidad de 10 líneas.célula-1 al mismo tiempo. Los contenidos de flavonoides, DPPH y auxina mostraron una tendencia estacional opuesta, alcanzando los niveles máximos en la estación húmeda. Este estudio aporta nueva información sobre las condiciones ambientales que pueden provocar cambios en la actividad antioxidante y la composición bioquímica de esta especie con vistas al desarrollo de bioproductos para diferentes sectores industriales como el alimentario, el farmacéutico y el de los fertilizantes en Ecuador. Palabras claves: Alga roja; Fenoles; Flavonoides; Antioxidante; Composición bioquímica; Variación estacional; densidad de siembra.

Neuroprotective Potentials of Marine Algae and Their Bioactive Metabolites: Pharmacological Insights and Therapeutic Advances

Beyond their significant contribution to the dietary and industrial supplies, marine algae are considered to be a potential source of some unique metabolites with diverse health benefits. The pharmacological properties, such as antioxidant, anti-inflammatory, cholesterol homeostasis, protein clearance and anti-amyloidogenic potentials of algal metabolites endorse their protective efficacy against oxidative stress, neuroinflammation, mitochondrial dysfunction, and impaired proteostasis which are known to be implicated in the pathophysiology of neurodegenerative disorders and the associated complications after cerebral ischemia and brain injuries. As was evident in various preclinical studies, algal compounds conferred neuroprotection against a wide range of neurotoxic stressors, such as oxygen/glucose deprivation, hydrogen peroxide, glutamate, amyloid β, or 1-methyl-4-phenylpyridinium (MPP+) and, therefore, hold therapeutic promise for brain disorders. While a significant number of algal compounds with promising neuroprotective capacity have been identified over the last decades, a few of them have had access to clinical trials. However, the recent approval of an algal oligosaccharide, sodium oligomannate, for the treatment of Alzheimer's disease enlightened the future of marine algae-based drug discovery. In this review, we briefly outline the pathophysiology of neurodegenerative diseases and brain injuries for identifying the targets of pharmacological intervention, and then review the literature on the neuroprotective potentials of algal compounds along with the underlying pharmacological mechanism, and present an appraisal on the recent therapeutic advances. We also propose a rational strategy to facilitate algal metabolites-based drug development.